Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 Oct 24, 2026 11:18AM

Investigational vaccine shows strong immune responses in infants equivalent to PREVNAR 20® on shared serotypes and for five new serotypes, potentially offering the broadest protection against invasive pneumococcal disease (IPD) for pediatric population in the U.S.

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced detailed results across serotypes from a Phase 2 study (NCT06524414) for its investigational 25-valent pneumococcal conjugate vaccine... (continue reading...)


IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial Oct 24, 2026 10:35AM

Novel combination demonstrated a median overall survival of nearly two years, the longest benefit ever reported in extensive stage disease in a Phase III trial

Results reinforce IMFINZI as the backbone immunotherapy across stages of small cell lung cancer

WILMINGTON, Del.--(BUSINESS WIRE)-- Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly... (continue reading...)


Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer Oct 24, 2026 10:30AM

More than three quarters of patients were still alive two years after treatment with perioperative IMFINZI plus three cycles of EV given before surgery

Data demonstrated statistically significant and clinically meaningful survival benefit and manageable safety profile

WILMINGTON, Del.--(BUSINESS WIRE)-- Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant... (continue reading...)


Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026 Oct 24, 2026 08:00AM

AirLink 5G Solutions Keep First Responders Connected During Peak Network Demand

CAMARILLO, Calif.--(BUSINESS WIRE)-- Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductors powering AI data center networking and intelligent, connected Internet of Things (“IoT”) devices worldwide, is adding new resilient communications building blocks to its AirLink® 5G Networking Solutions. Semtech will demonstrate the new capabilities in booth... (continue reading...)


ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence Oct 24, 2026 08:00AM
  • Interim analysis results from the Phase III DASL-HiCaP trial show a statistically significant 58% reduction in the risk of metastasis or death with NUBEQA® (darolutamide) versus placebo in addition to androgen deprivation therapy (ADT) and radiation therapy (hazard ratio [HR] 0.42; 95% CI: 0.27–0.66; p=0.0001)
  • Four-year metastasis-free survival rate in trial reached 95% with NUBEQA compared to 88% with placebo, alongside secondary endpoint improvements and a safety... (continue reading...)

More Business Wire

View Older Stories

Oct 24, 2026 07:00AM Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Oct 24, 2026 04:15AM BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
Oct 24, 2026 04:15AM CatalYm Presents Phase 2 Data Showing Visugromab Substantially Enhances the Clinical Benefit of PD-1 Inhibition in Neoadjuvant Bladder Cancer at ESMO 2026
Oct 23, 2026 10:08PM Slate Grocery REIT Announces Receipt of Interim Order, and Provides Meeting and Circular Details
Oct 23, 2026 08:37PM Genesis Healthcare Announces Effective Date of Chapter 11 Plan Following Consummation of Sale to West State Street
Oct 23, 2026 07:59PM US Metro Bancorp Announces Third Quarter 2026 Results
Oct 23, 2026 07:20PM Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
Oct 23, 2026 07:16PM Hawaiian Electric Industries to Announce Third Quarter 2026 Results November 6
Oct 23, 2026 06:45PM Principal Real Estate Income Fund Announces Changes in Portfolio Management
Oct 23, 2026 05:21PM KBRA Assigns BBB- Rating to Board of Education of the City of Chicago Unlimited Tax General Obligation Bonds (Dedicated Revenues), Series 2026A; Affirms Related Ratings; Outlook Remains Negative
Oct 23, 2026 05:21PM Best’s Commentary: AM Best Comments on Impact of Civil Unrest on France’s Insurers
Oct 23, 2026 05:05PM Vital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores
Oct 23, 2026 05:03PM Notice to Market: Nu Holdings Ltd.
Oct 23, 2026 05:02PM KBRA Assigns Preliminary Ratings to US Signal Issuer LLC and US Signal Co-Issuer LLC Series 2026-1/2
Oct 23, 2026 05:00PM AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Oct 23, 2026 05:00PM Hamilton ETFs Announces October 2026 Monthly & Upcoming Semi-Monthly Cash Distributions
Oct 23, 2026 04:45PM Lewis Apartments Opens Independence Rental-Home Community Near Downtown Sacramento
Oct 23, 2026 04:45PM Myers Industries Announces Quarterly Dividend
Oct 23, 2026 04:37PM Summit Therapeutics and Lunit Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
Oct 23, 2026 04:33PM PRIVACY ALERT: AWKO Law LLP Investigates Quest Diagnostics for Data Breach of Patient Records
Oct 23, 2026 04:21PM Delek Logistics Partners, LP Increases Quarterly Cash Distribution to $1.14 per Common Limited Partner Unit
Oct 23, 2026 04:16PM AM Best Affirms Credit Ratings of Redbridge Insurance Company Limited and Redbridge Insurance Company
Oct 23, 2026 04:15PM FICO Holds Mortgage Score Pricing at $10 for Lenders Enrolled in Preferred Program
Oct 23, 2026 04:15PM NIKE, Inc. Announces 2026 Investor Day Webcast
Oct 23, 2026 04:10PM Surf Air Mobility to Announce Third Quarter 2026 Financial Results on November 5, 2026
Oct 23, 2026 04:05PM GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Oct 23, 2026 04:05PM PEOPLES FINANCIAL SERVICES CORP. Declares Fourth Quarter 2026 Dividend
Oct 23, 2026 04:05PM Logitech Launches ‘Chain Reaction’ to Accelerate Supply Chain Decarbonization towards 2030 Climate Goals
Oct 23, 2026 04:05PM AMTD Digital’s Total Assets Expand to US$1.2 Billion with Net Assets at US$630.6 Million, Maintaining Robust Profitability of US$42.4 Million
Oct 23, 2026 04:05PM River City Bank Reports Third Quarter 2026 Results and Announces a Quarterly Cash Dividend
Oct 23, 2026 04:03PM Stem Announces Notification of Noncompliance with NYSE Continued Listing Standards
Oct 23, 2026 04:00PM Orthofix to Report Third Quarter 2026 Financial Results
Oct 23, 2026 04:00PM Salesforce Grants Equity Awards to m3ter and Fin Under Its Inducement Equity Incentive Plan
Oct 23, 2026 04:00PM GondolaBio and Children’s Tumor Foundation Announce Partnership to Advance GondolaBio’s Neurofibromatosis Type 1 Program
Oct 23, 2026 04:00PM NYSE to Commence Delisting Proceedings Against Elme Communities (ELME)
Oct 23, 2026 02:50PM Wolters Kluwer launches agentic tax preparation in CCH Axcess, the agentic platform for tax and accounting
Oct 23, 2026 02:48PM on!® Crowns Team Grass League Champions at Inaugural on!vitational™ Golf Tournament
Oct 23, 2026 02:20PM FHLBank Chicago Announces Q3 2026 Financial Highlights
Oct 23, 2026 02:16PM CUPE: Government Has the Power to End Uncertainty for Nova Scotia's School Communities
Oct 23, 2026 02:15PM Elucid Statement on Heartflow Lawsuit: Reaffirms Mission, Confidence in Its Technology, and Commitment to Patients and Physicians
Oct 23, 2026 02:03PM Liquid Strategies Launches OVQ, Bringing Put-Spread Income Strategy to the Nasdaq-100
Oct 23, 2026 01:52PM Infinity Hires Meta Superintelligence Labs Chip Veteran and the CUDA Educator Who's Taught Two Million Engineers
Oct 23, 2026 01:49PM PennyMac Mortgage Investment Trust Reschedules Third Quarter 2026 Earnings Call to 6:30 PM ET on Thursday, October 29
Oct 23, 2026 01:46PM KBRA Assigns Preliminary Ratings to Foundation Finance Trust 2026-2
Oct 23, 2026 01:42PM PennyMac Financial Services, Inc. Reschedules Third Quarter 2026 Earnings Call to 5:30 PM ET on Thursday, October 29
Oct 23, 2026 01:42PM AM Best Affirms Credit Ratings of The Hand-in-Hand Mutual Fire Insurance Company Limited and Hand-in-Hand Mutual Life Assurance Company Limited
Oct 23, 2026 01:42PM Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidne
Oct 23, 2026 01:38PM NextGen Healthcare Appoints Anthony Palladino as Chief Financial Officer
Oct 23, 2026 01:37PM Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
Oct 23, 2026 01:30PM Genentech Presents Interim Phase III Data Showing Sefaxersen Significantly Reduced Proteinuria in People With IgA Nephropathy (IgAN)
View Older Stories